Biography and Research Information
OverviewAI-generated summary
Nancy Green is a Professor at the University of Arkansas for Medical Sciences with an h-index of 41 and over 7,600 citations across 451 publications. Her research interests include sickle cell disease, particularly in children and adolescents. She has investigated the use of hydroxyurea as a treatment, examining adherence and changes in its use following guideline revisions. Her work also explores the neurological complications of sickle cell anemia, including the use of MRI and angiography, and the potential of neurofilament light chain as a biomarker for cerebrovascular disease.
Green's research extends to public health initiatives, such as newborn screening programs for sickle cell disease in Africa. She has also studied the impact of social determinants of health, including food insecurity and housing instability, on children with sickle cell disease. Her work further addresses healthcare practices, including contraceptive counseling for female adolescents with sickle cell disease.
Her collaborators at the University of Arkansas for Medical Sciences include Steven R. Post, Michele Cottler-Fox, Mayumi Nakagawa, and Gina Drobena. Green is recognized as a high-impact researcher due to her highly cited work.
Metrics
- h-index: 41
- Publications: 443
- Citations: 7,703
Selected Publications
-
Impact of New Hematopoietic Progenitor Cell Collection Goals on Apheresis and Cell Therapy Laboratory Services (2025)
-
AUTOLOGOUS HEMATOPOIETIC PROGENITOR CELL (HPC) BOOSTS AFTER CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY: IMPACT ON THE CELL THERAPY LABORATORY AND STORAGE FACILITY (2025)
Collaboration Network
Top Collaborators
- Brain Magnetic Resonance Imaging and Angiography in Children with Sickle Cell Anaemia in Uganda in a Cross-Sectional Sample
- Neurofilament light chain: A potential biomarker for cerebrovascular disease in children with sickle cell anaemia
- Neurocognitive impairment in Ugandan children with sickle cell anemia compared to sibling controls: a cross-sectional study
- Hydroxyurea therapy for neurological and cognitive protection in pediatric sickle cell anemia in Uganda (BRAIN SAFE II): Protocol for a single-arm open label trial
- Academic Proficiency in Ugandan Children With Sickle Cell Anemia: A Cross‐Sectional Study
Showing 5 of 19 shared publications
- Brain Magnetic Resonance Imaging and Angiography in Children with Sickle Cell Anaemia in Uganda in a Cross-Sectional Sample
- Neurofilament light chain: A potential biomarker for cerebrovascular disease in children with sickle cell anaemia
- Neurocognitive impairment in Ugandan children with sickle cell anemia compared to sibling controls: a cross-sectional study
- Hydroxyurea therapy for neurological and cognitive protection in pediatric sickle cell anemia in Uganda (BRAIN SAFE II): Protocol for a single-arm open label trial
- Academic Proficiency in Ugandan Children With Sickle Cell Anemia: A Cross‐Sectional Study
Showing 5 of 19 shared publications
- Brain Magnetic Resonance Imaging and Angiography in Children with Sickle Cell Anaemia in Uganda in a Cross-Sectional Sample
- Neurofilament light chain: A potential biomarker for cerebrovascular disease in children with sickle cell anaemia
- Neurocognitive impairment in Ugandan children with sickle cell anemia compared to sibling controls: a cross-sectional study
- Hydroxyurea therapy for neurological and cognitive protection in pediatric sickle cell anemia in Uganda (BRAIN SAFE II): Protocol for a single-arm open label trial
- Academic Proficiency in Ugandan Children With Sickle Cell Anemia: A Cross‐Sectional Study
Showing 5 of 15 shared publications
- Brain Magnetic Resonance Imaging and Angiography in Children with Sickle Cell Anaemia in Uganda in a Cross-Sectional Sample
- Neurofilament light chain: A potential biomarker for cerebrovascular disease in children with sickle cell anaemia
- Neurocognitive impairment in Ugandan children with sickle cell anemia compared to sibling controls: a cross-sectional study
- Academic Proficiency in Ugandan Children With Sickle Cell Anemia: A Cross‐Sectional Study
- Academic achievement in Ugandan children with sickle cell anaemia: A cross-sectional study
Showing 5 of 15 shared publications
- Brain Magnetic Resonance Imaging and Angiography in Children with Sickle Cell Anaemia in Uganda in a Cross-Sectional Sample
- Neurofilament light chain: A potential biomarker for cerebrovascular disease in children with sickle cell anaemia
- Neurocognitive impairment in Ugandan children with sickle cell anemia compared to sibling controls: a cross-sectional study
- Hydroxyurea therapy for neurological and cognitive protection in pediatric sickle cell anemia in Uganda (BRAIN SAFE II): Protocol for a single-arm open label trial
- Academic Proficiency in Ugandan Children With Sickle Cell Anemia: A Cross‐Sectional Study
Showing 5 of 14 shared publications
- Hydroxyurea therapy for neurological and cognitive protection in pediatric sickle cell anemia in Uganda (BRAIN SAFE II): Protocol for a single-arm open label trial
- Hydroxyurea Therapy for Neurological and Cognitive Protection in Pediatric Sickle Cell Anemia in Uganda (BRAIN SAFE II): Protocol for a single-arm open label trial
- Acute Stroke in Children with Sickle Cell Anemia without Abnormal Transcranial Doppler in a Hydroxyurea Trial in Uganda
- Neurocognitive Improvement with Hydroxyurea Therapy in Children with Sickle Cell Anemia in Uganda: Analysis from the Completed 30-Month BRAIN Safe II Trial
- Incident Stroke in Pediatric Sickle cell Anemia Despite Overall Improved Transcranial Doppler Velocity in a Ugandan Hydroxyurea Trial: Antecedent and ongoing risks
Showing 5 of 13 shared publications
- Hydroxyurea therapy for neurological and cognitive protection in pediatric sickle cell anemia in Uganda (BRAIN SAFE II): Protocol for a single-arm open label trial
- Academic Proficiency in Ugandan Children With Sickle Cell Anemia: A Cross‐Sectional Study
- Hydroxyurea Therapy for Neurological and Cognitive Protection in Pediatric Sickle Cell Anemia in Uganda (BRAIN SAFE II): Protocol for a single-arm open label trial
- Academic achievement in Ugandan children with sickle cell anaemia: A cross-sectional study
- Neurocognitive Improvement with Hydroxyurea Therapy in Children with Sickle Cell Anemia in Uganda: Analysis from the Completed 30-Month BRAIN Safe II Trial
Showing 5 of 13 shared publications
- Pediatric hematology providers’ contraceptive practices for female adolescents and young adults with sickle cell disease: A national survey
- Hydroxyurea Adherence for Personal Best in Sickle Cell Treatment (HABIT) efficacy trial: Community health worker support may increase hydroxyurea adherence of youth with sickle cell disease
- Mental health assessment of youth with sickle cell disease and their primary caregivers during the COVID‐19 pandemic
- Mental and Emotional Health of Caregivers of Youth with Sickle Cell Disease: A Systematic Review
- Assessing multilevel barriers to hydroxyurea adherence in youth with sickle cell disease using pharmacy‐based refill records
Showing 5 of 12 shared publications
- Brain Magnetic Resonance Imaging and Angiography in Children with Sickle Cell Anaemia in Uganda in a Cross-Sectional Sample
- Neurofilament light chain: A potential biomarker for cerebrovascular disease in children with sickle cell anaemia
- Neurocognitive impairment in Ugandan children with sickle cell anemia compared to sibling controls: a cross-sectional study
- Academic Proficiency in Ugandan Children With Sickle Cell Anemia: A Cross‐Sectional Study
- Academic achievement in Ugandan children with sickle cell anaemia: A cross-sectional study
Showing 5 of 12 shared publications
- Pediatric hematology providers’ contraceptive practices for female adolescents and young adults with sickle cell disease: A national survey
- Hydroxyurea Adherence for Personal Best in Sickle Cell Treatment (HABIT) efficacy trial: Community health worker support may increase hydroxyurea adherence of youth with sickle cell disease
- Mental health assessment of youth with sickle cell disease and their primary caregivers during the COVID‐19 pandemic
- Assessing multilevel barriers to hydroxyurea adherence in youth with sickle cell disease using pharmacy‐based refill records
- National Survey of Pediatric Sickle Cell Providers on Their Contraceptive Practices for Female Patients
Showing 5 of 10 shared publications
- Academic Proficiency in Ugandan Children With Sickle Cell Anemia: A Cross‐Sectional Study
- Academic achievement in Ugandan children with sickle cell anaemia: A cross-sectional study
- Acute Stroke in Children with Sickle Cell Anemia without Abnormal Transcranial Doppler in a Hydroxyurea Trial in Uganda
- Incident Stroke in Pediatric Sickle cell Anemia Despite Overall Improved Transcranial Doppler Velocity in a Ugandan Hydroxyurea Trial: Antecedent and ongoing risks
- Neurocognitive gains among Ugandan children with sickle cell anemia on hydroxyurea: 18-month interim trial results
Showing 5 of 9 shared publications
- Neurofilament light chain: A potential biomarker for cerebrovascular disease in children with sickle cell anaemia
- Hydroxyurea therapy for neurological and cognitive protection in pediatric sickle cell anemia in Uganda (BRAIN SAFE II): Protocol for a single-arm open label trial
- Hydroxyurea Therapy for Neurological and Cognitive Protection in Pediatric Sickle Cell Anemia in Uganda (BRAIN SAFE II): Protocol for a single-arm open label trial
- Neurocognitive Improvement with Hydroxyurea Therapy in Children with Sickle Cell Anemia in Uganda: Analysis from the Completed 30-Month BRAIN Safe II Trial
- Neurocognitive gains among Ugandan children with sickle cell anemia on hydroxyurea: 18-month interim trial results
Showing 5 of 8 shared publications
- Academic Proficiency in Ugandan Children With Sickle Cell Anemia: A Cross‐Sectional Study
- Academic achievement in Ugandan children with sickle cell anaemia: A cross-sectional study
- Acute Stroke in Children with Sickle Cell Anemia without Abnormal Transcranial Doppler in a Hydroxyurea Trial in Uganda
- Incident Stroke in Pediatric Sickle cell Anemia Despite Overall Improved Transcranial Doppler Velocity in a Ugandan Hydroxyurea Trial: Antecedent and ongoing risks
- Neurocognitive gains among Ugandan children with sickle cell anemia on hydroxyurea: 18-month interim trial results
Showing 5 of 8 shared publications
- Academic Proficiency in Ugandan Children With Sickle Cell Anemia: A Cross‐Sectional Study
- Academic achievement in Ugandan children with sickle cell anaemia: A cross-sectional study
- Incident Stroke in Pediatric Sickle cell Anemia Despite Overall Improved Transcranial Doppler Velocity in a Ugandan Hydroxyurea Trial: Antecedent and ongoing risks
- Neurocognitive gains among Ugandan children with sickle cell anemia on hydroxyurea: 18-month interim trial results
- Incident Stroke in Pediatric Sickle Cell Anemia Despite Overall Improved Transcranial Doppler Velocity in a Ugandan Hydroxyurea Trial: Antecedent and Ongoing Risks
Showing 5 of 8 shared publications
- Hydroxyurea Adherence for Personal Best in Sickle Cell Treatment (HABIT) efficacy trial: Community health worker support may increase hydroxyurea adherence of youth with sickle cell disease
- Mental health assessment of youth with sickle cell disease and their primary caregivers during the COVID‐19 pandemic
- Assessing multilevel barriers to hydroxyurea adherence in youth with sickle cell disease using pharmacy‐based refill records
- Mental Health Assessment of Youth with Sickle Cell Disease and Their Primary Caregivers During the COVID-19 Pandemic
- Assessing Multi-Level Barriers to Medication Adherence in Youth with Sickle Cell Disease Using Pharmacy-Based Prescription Refill Data
Showing 5 of 7 shared publications
Similar Researchers
Based on overlapping research topics